NTLA Intellia Therapeutics Inc

USD 16.00 -0.06 ( -0.37)%
Icon

Intellia Therapeutics Inc (NTLA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 16.00

-0.06 (-0.37)%

USD 1.45B

3.37M

USD 50.86(+217.86%)

USD 59.56 (+272.25%)

Icon

NTLA

Intellia Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 16.00
-0.06 ( -0.37)%

ETFs Holding Intellia Therapeutics Inc (NTLA)

Symbol Name Exchange NTLA's Weight Expense Ratio Price(Change) Market Cap
ARCG:LSE
ARK Genomic Revolution UC.. LSE 4.12 % 0.00 % +6.78 (+1.88%) USD3.68M

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...